Related Experiment Video
Updated: Sep 17, 2025
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
From cholesterol to glucose: uncovering how statins induce β-cell dysfunction to promote type 2 diabetes
Abstract:
Statins are the most commonly used cholesterol-lowering medications, with proven efficacy in reducing cardiovascular disease in humans; however, statins are associated with a higher risk of new-onset type 2 diabetes (T2D). Mechanisms contributing to statin-induced diabetes are not well understood and may include effects on body composition, tissue insulin sensitivity, and/or pancreatic β-cell function. Given the essential role of the β-cell in maintaining normoglycemia, this review focuses on how statins may lead to the demise of the β-cell. We revisit what is known about the impact of statins on inhibition of the mevalonate pathway, including blockade of the synthesis of cholesterol and non-cholesterol products. We discuss aberrant expression of key β-cell genes and proteins, as well as dysregulation of β-cell components that facilitate normal insulin secretion, e.g., mitochondria and calcium channels. Importantly, we highlight areas that are understudied, including how statins alter cholesterol transport and metabolism in the β-cell, and the role of sex/gender in statin-induced β-cell dysfunction. As the number of statin users increases, there is an urgent need to address these gaps in our knowledge in order to shed light on strategies that limit statin-induced T2D.
Insights
Statins, widely used for cardiovascular health, may increase type 2 diabetes risk by impairing pancreatic beta-cell function. Further research is crucial to understand and mitigate this risk.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Background:
- Statins are primary lipid-lowering drugs for cardiovascular disease prevention.
- A known side effect of statin use is an increased risk of new-onset type 2 diabetes (T2D).
- The precise mechanisms underlying statin-induced T2D remain incompletely understood.
Purpose of the Study:
- This review focuses on the detrimental effects of statins on pancreatic beta-cell function.
- It aims to elucidate how statins contribute to beta-cell dysfunction and demise.
- The review highlights knowledge gaps concerning statin's impact on beta-cells.
Main Methods:
- Review of existing literature on statin mechanisms.
- Analysis of the mevalonate pathway's role in statin-induced T2D.
- Discussion of beta-cell gene expression, protein regulation, and cellular components.
Main Results:
- Statins inhibit the mevalonate pathway, affecting cholesterol and non-cholesterol synthesis.
- Aberrant gene/protein expression and dysregulation of beta-cell components (mitochondria, calcium channels) are implicated.
- Statin effects on beta-cell cholesterol metabolism and sex/gender differences are understudied.
Conclusions:
- Statins can negatively impact pancreatic beta-cell function, potentially leading to T2D.
- Understanding these mechanisms is vital for managing statin-associated diabetes risk.
- Further research into beta-cell cholesterol metabolism and sex/gender influences is urgently needed.
Related Concept Videos
01:36Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
01:22Diabetes Mellitus: Type 2 and Gestational
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents